J Kenneth Glass - Net Worth and Insider Trading
J Kenneth Glass Net Worth
The estimated net worth of J Kenneth Glass is at least $1 Million dollars as of 2024-12-14. J Kenneth Glass is the Director of FedEx Corp and owns about 5,000 shares of FedEx Corp (FDX) stock worth over $1 Million. J Kenneth Glass is also the Director of Oncternal Therapeutics Inc and owns about 178 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $94. Details can be seen in J Kenneth Glass's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Kenneth Glass has not made any transactions after 2016-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Kenneth Glass
J Kenneth Glass Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Kenneth Glass owns 3 companies in total, including Oncternal Therapeutics Inc (ONCT) , First Horizon Corp (FHN) , and FedEx Corp (FDX) .
Click here to see the complete history of J Kenneth Glass’s form 4 insider trades.
Insider Ownership Summary of J Kenneth Glass
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2016-03-01 | director |
| FHN | First Horizon Corp | 2003-07-01 | director & President & CEO |
| FDX | FedEx Corp | 2003-12-31 | director |
J Kenneth Glass Latest Holdings Summary
J Kenneth Glass currently owns a total of 2 stocks. Among these stocks, J Kenneth Glass owns 5,000 shares of FedEx Corp (FDX) as of December 31, 2003, with a value of $1 Million and a weighting of 99.99%. J Kenneth Glass also owns 178 shares of Oncternal Therapeutics Inc (ONCT) as of March 1, 2016, with a value of $94 and a weighting of 0.01%.
Latest Holdings of J Kenneth Glass
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FDX | FedEx Corp | 2003-12-31 | 5,000 | 283.42 | 1,417,100 |
| ONCT | Oncternal Therapeutics Inc | 2016-03-01 | 178 | 0.53 | 94 |
Holding Weightings of J Kenneth Glass
J Kenneth Glass Form 4 Trading Tracker
According to the SEC Form 4 filings, J Kenneth Glass has made a total of 0 transactions in FedEx Corp (FDX) over the past 5 years. The most-recent trade in FedEx Corp is the acquisition of 5,000 shares on December 31, 2003, which cost J Kenneth Glass around $341,700.
According to the SEC Form 4 filings, J Kenneth Glass has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 31 shares on March 1, 2016, which cost J Kenneth Glass around $26,400.
Insider Trading History of J Kenneth Glass
- 1
J Kenneth Glass Trading Performance
GuruFocus tracks the stock performance after each of J Kenneth Glass's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Kenneth Glass is 15.41%. GuruFocus also compares J Kenneth Glass's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Kenneth Glass within 3 months outperforms 9 times out of 17 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Kenneth Glass's insider trading performs compared to the benchmark.
Performance of J Kenneth Glass
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.4 | | | | | |
| Relative Return to S&P 500(%) | 12.35 | | | | | |
J Kenneth Glass Ownership Network
Ownership Network List of J Kenneth Glass
Ownership Network Relation of J Kenneth Glass
J Kenneth Glass Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
J Kenneth Glass is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, J Kenneth Glass made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 10,980 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
J Kenneth Glass Mailing Address
Above is the net worth, insider trading, and ownership report for J Kenneth Glass. You might contact J Kenneth Glass via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
